
ABOUT US
With a rich heritage dating back hundreds of years, Cytiva brings a wealth of technical expertise and talent, a broad and deep portfolio, and exceptional service help researchers and biopharma advance therapeutics at every stage from discovery to delivery.
We supply the tools and support our customers need to work better, faster, and safer, leading to the delivery of transformative medicines to patients. Our combined portfolio includes well-recognized names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™. Visit cytiva.com to learn more.
VIDEOS
FEATURED PRODUCTS
-
MabSelect™ VL resin — protein L resin for affinity capture of antibody Fabs, bispecifics, and other variants containing a kappa light chain.
-
Supplements cell culture with amino acids, vitamins, and glucose and manufactured to meet cGMP manufacturing standards and QC specifications.
-
ÄKTA™ chromatography systems can handle both simple and complex purification tasks and accelerate daily routines. All systems are controlled by UNICORN™ software, a common control platform and user interface for all scales of operation.
-
Cytiva provides filtration solutions and support for integrated bioprocessing applications at every step and every scale of the drug development, validation and manufacturing process.
-
We offer a range of systems, accessories, and reagents for label-free analysis using microcalorimetry or surface plasmon resonance (SPR). These techniques provide information-rich, real time data without the use of labels.
-
Automated PUPSIT and sterile filtration with enhanced product recovery.
-
Protein A resin with high binding capacity for cost-efficient separation mAbs.
-
Accelerate your biomanufacturing capacity with purpose-built modules
KUBio™ box modular bioprocessing environments are designed to help biopharmaceutical manufacturers bring high-quality biopharmaceuticals to market more quickly. By reducing typical design and construction times and streamlining process execution, they support future expansion and replication needs. Available KUBio™ box modular environments for biosafety levels 1 and 2 (BSL-1 and BSL-2) can be delivered in 10 to 15 months for implementation inside existing infrastructure. The result? Reduced project risk, accelerated delivery of next-gen therapies, and greater flexibility at different production scales and product technologies.
-
Transform your space to fit your needs
Configurable FlexFactory™ biomanufacturing process trains can help scientists better control the production and processing of different viral vectors and new modalities—all within the same space. Plan your agile manufacturing strategy with greater efficiency and integration to address current and future capacity needs.
-
Single-use, automated filtration system designed to deliver robust process control during the clarification/harvest step.
BROCHURES AND DATASHEETS
- Software And Server Upgrade For Your Bioprocess System
- Is Now The Time To Upgrade Your ÄKTAprocess™?
- Bioreactor Software Upgrade: Enhance Your User Experience
- Maximize The Uptime, Performance And Investment Of Your System
- Virtual Reality Operator Training Experience
- Care And Troubleshooting For Your Chromatography Columns
- Chromatography System Basic Operator Care And Troubleshooting Training
- Basic Care And Troubleshooting For Your Chromatography Systems
- Basic Care And Troubleshooting For Your Chromatography Systems
- Basic Care And Troubleshooting For Your Chromatography Systems
WEBINARS
APPLICATION NOTES
- Optimizing TFF And SPTFF For High-Concentration mAb Formulations
- Selecting A Platform Filter For High Concentration mAbs
- Packing MabSelect™ And MabSelect SuRe™ Resins Using Verified Methods
- Production Of A Highly Concentrated Monoclonal Antibody
- Extractables In Single-Use Systems Used In ADC Manufacturing
- TFF Cassettes With 100 kDa Membranes For RNA And LNP Applications
- Media And Buffer Mixing Using The Xcellerex™ Magnetic Mixer
- Determining The Power Numbers For A Single-Use Mixing System
- Adapting Single-Use Chromatography To Manufacturing Scale
- Developing A Large-Scale Tangential Flow Filtration Process
CONTACT INFORMATION
Cytiva
100 Results Way
Marlborough, MA 08855-1327
UNITED STATES
Phone: 800-526-3593
FEATURED ARTICLES
-
Discover how rising competition, niche patient populations, and evolving therapies are reshaping sterile injectable drug development with cutting-edge technologies.
-
Sterility in injectable drug manufacturing is vital for patient safety and efficiency. Discover how biofluorescent particle counters revolutionize contamination control, regulatory compliance, and operational excellence in modern pharma.
-
Implementing PUPSIT and other integrity testing methods is crucial for manufacturers to reduce contamination risks and ensure drug product safety. Learn how your company can adhere to updated regulatory guidelines for sterility.
-
Pre-use, post-sterilization integrity testing (PUPSIT) is vital for contamination control to ensure the integrity of sterilized equipment before use. Learn how PUPSIT can enhance safety and quality in your protocols.
-
Robotic gloveless isolators provide exceptional automation to eliminate human intervention and reduce contamination risk. Discover how they ensure compliance with the EU Annex 1 guideline to enhance sterility, precision, and monitoring.
-
Are robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.
-
The 2025 BioPhorum report highlights challenges and trends in drug filling operations and how they are advancing towards biofluorescent particle counters. Discover an approach that aligns with industry needs.
-
CDMOs must innovate production architectures to meet the demands of advanced therapeutics to ensure a reliable supply and compliance. Discover how these approaches advance modern medicine and improve patient outcomes.
-
The monoclonal antibody intermediate is engineered for precise delivery of the linker-payload complex. Discover how rigorous storage measures ensure its quality, which is crucial for successful conjugation and functionality.
-
Implement strategies to reduce unplanned downtime and keep your biomanufacturing on track with a checklist that covers maintenance, monitoring, and contingency planning to enhance reliability and resilience.
NEWS
- Ribobay Pharma Boosts CRDMO Offerings With Cytiva's First FlexFactory Platform For Oligonucleotides
- Cytiva Expanding US Operations
- Rockwell Automation And Cytiva Collaborate To Digitalize Operations At Innovative Pharmaceutical Development Center
- Cytiva To provide Arranta Bio 'Idea To Injection' solutions For integrated Manufacturing Of mRNA Products
- Cytiva Attains Business Continuity Management System ISO Certification
- Cytiva Acquires GoSilico To Strengthen Digital Capabilities In Bioprocessing
- Cytiva Acquires Vanrx Pharmasystems, Canadian Aseptic Filling Innovator
- Cytiva Delivers KUBio To Lonza
- Cytiva Provides Akron Biotech With FlexFactory For The Manufacture Of Plasmid DNA
- Cytiva's Fibro PrismA Technology Accelerates mAb Purification In LifeArc's Covid-19 Research